Endogenous opioids: The downside of opposing stress

Neurobiology of Stress

Volumn 1, Issue 1, 2015, Pages 23-32

  Valentino, Rita J ^a,b   Van Bockstaele, Elisabeth ^c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Corticotropin releasing factor; Enkephalin; Locus coeruleus; M opioid receptor

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; DYNORPHIN; ENDORPHIN; ENKEPHALIN; MU OPIATE RECEPTOR; NALOXONE; NORADRENALIN; OPIATE; PREPRODYNORPHIN; PREPROENKEPHALIN; PROOPIOMELANOCORTIN;

ACUTE STRESS; ADAPTIVE BEHAVIOR; ADRENERGIC SYSTEM; AROUSAL; ARTICLE; AVERSIVE BEHAVIOR; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CENTRAL NUCLEUS (AMYGDALA); COGNITION; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMUNOREACTIVITY; LOCUS CERULEUS; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL STRESS; STIMULUS RESPONSE; STRESS;

EID: 84921910396     PISSN: None     EISSN: 23522895     Source Type: Journal    
DOI: 10.1016/j.ynstr.2014.09.006     Document Type: Review

References (195)

1. Abercrombie, E.D., Jacobs, B.L., 1988. Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not nonstressful conditions. Brain Res. 441, 362-366
2. Aghajanian, G.K., Wang, Y.-Y., 1987. Common alpha2 and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices. Neuropharmacology 26, 793-799
3. Akil, H., Watson, S.J., Young, E., Lewis, M.E., Khachaturian, H., Walker, J.M., 1984. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7, 223-255
4. Aston-Jones, G., Bloom, F.E., 1981. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J. Neurosci. 1, 887-900
5. Aston-Jones, G., Bloom, F.E., 1981. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1, 876-886
6. Aston-Jones, G., Cohen, J.D., 2005. An integrative theory of locus coeruleusnorepinephrine function: adaptive gain and optimal performance. Annu. Rev Neurosci. 28, 403-450
7. Aston-Jones, G., Shipley, M.T., Grzanna, R., 1995. The locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos, G. (Ed.), The Rat Brain. Academic Press, pp. 183-213
8. Bale, T.L., Vale, W.W., 2004. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44, 525-557
9. Beck, C.H.M., Fibiger, H.C., 1995. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J. Neurosci. 15, 709-720
10. Berridge, C.W., Foote, S.L., 1991. Effects of locus coeruleus activation on electroencephalographic activity in the neocortex and hippocampus. J. Neurosci. 11, 3135-3145
11. Berridge, C.W., Waterhouse, B.D., 2003. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 42, 33-84
12. Berridge, C.W., Page, M.E., Valentino, R.J., Foote, S.L., 1993. Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience 55, 381-383
13. Bonaz, B., Tache, Y., 1994. Water-avoidance stress-induced c-fos expression in the rat brain and stimulation of fecal output: role of corticotropin-releasing factor. Brain Res. 641, 21-28
14. Bouret, S., Sara, S.J., 2005. Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci. 28, 574-582
15. Bowers, M.E., Choi, D.C., Ressler, K.J., 2012. Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y. Physiol. Behav. 107, 699-710
16. Bradbury, A.F., Smyth, D.G., Snell, C.R., 1976. Biosynthetic origin and receptor conformation of methionine enkephalin. Nature 260, 165-166
17. Bremner, J.D., Licinio, J., Darnell, A., Krystal, J.H., Owens, M.J., Southwick, S.M., Nemeroff, C.B., Charney, D.S., 1997. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am. J. Psych. 154, 624-629
18. Breslau, N., 2002. Gender differences in trauma and posttraumatic stress disorder. J. Gend. Specif. Med. 5, 34-40
19. Britton, E.R., Kooob, G.F., Rivier, F., Vale, W., 1982. Intraventricular corticotropin releasing factor enhances behavioral effects of novelty. Life Sci. 31, 363-367
20. Britton, K.T., Segal, D.S., Kuczenski, R., Hauger, R., 1992. Dissociation between in vivo hippocampal norepinephrine response and behavioral/neuroendocrine responses to noise stress in rats. Brain Res. 574, 125-130
21. Brown, M.R., Fisher, L.A., 1985. Corticotropin-releasing factor: effects on the autonomic nervous systems and visceral systems. Fed. Proc. 44, 243-248
22. Brown, M.R., Fisher, L.A., Spiess, J., Rivier, C., Vale, W., 1982. Corticotropin-releasing factor (CRF): actions on the sympathetic nervous system and metabolism. Endocrinology 111, 928-931
23. Bryant, R.A., Creamer, M., O'Donnell, M., Silove, D., McFarlane, A.C., 2009. A study of the protective function of acute morphine administration on subsequent posttraumatic stress disorder. Biol. Psych. 65, 438-440
24. Bueno, L., Gue, M., 1988. Evidence for the involvement of corticotropin-releasing factor in the gastrointestinal disturbances induced by acoustic and cold stress in mice. Brain Res. 441, 1-4
25. Butler, P.D., Weiss, J.M., Stout, J.C., Nemeroff, C.B., 1990. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the LC. J. Neurosci. 10, 176-183
26. Campeau, S., Watson, S.J., 1997. Neuroendocrine and behavioral response and brain pattern of c-fos induction associated with audiogenic stress. J. Neuroendocrinol. 9, 577-588
27. Cassens, G., Roffman, M., Kuruc, A., Orsulak, P.J., Schildkraut, J.J., 1980. Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science 209, 1138-1139
28. Cassens, G., Kuruc, A., Roffman, M., Orsulak, P.J., Schildkraut, J.J., 1981. Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Brain Res. 2, 387-407
29. Ceccatelli, S., Orazzo, C., 1993. Effect of different types of stressors on peptide messenger ribonucleic acids in the hypothalamic paraventricular nucleus. Acta Endocrinol. (Copenh) 128, 485-492
30. Chaijale, N.N., Curtis, A.L., Wood, S.K., Zhang, X.Y., Bhatnagar, S., Reyes, B.A., Van Bockstaele, E.J., Valentino, R.J., 2013. Social stress engages opioid regulation of locus coeruleus norepinephrine neurons and induces a state of cellular and physical opiate dependence. Neuropsychopharmacology 38, 1833-1843
31. Chan, R.K.W., Sawchenko, P.E., 1995. Hemodynamic regulation of tyrosine hydroxylase messenger RNA in medullary catecholamine neurons: a c-fos-guided hybridization histochemical study. Neuroscience 66, 377-390
32. Chang, M.S., Sved, A.F., Zigmond, M.J., Austin, M.C., 2000. Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience 101, 131-139
33. Chavkin, C., 2013. Dynorphinestill an extraordinarily potent opioid peptide. Mol Pharmacol. 83, 729-736
34. Chrousos, G.P., 2000. Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J. Allergy Clin. Immunol. 106, S275-S291
35. Chrousos, G.P., 2000. The role of stress and the ypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int. J. Obes. Relat. Metab. Disord. 24, S50-S55
36. Chrousos, G.P., Gold, P.W., 1992. The concepts of stress and stress system disorders Overview of physical and behavioral homeostasis. Jama 267, 1244-1252
37. Clark, H.W., Masson, C.L., Delucchi, K.L., Hall, S.M., Sees, K.L., 2001. Violent traumatic events and drug abuse severity. J. Subst. Abuse Treat. 20, 121-127
38. Cole, B.J., Koob, G.F., 1988. Propranolol antagonizes the enhanced conditioned fear produced by corticotropin-releasing factor. J. Pharmacol. Exp. Ther. 247, 902-910
39. Comb, M., Seeburg, P.H., Adelman, J., Eiden, L., Herbert, E., 1982. Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA. Nature 295, 663-666
40. Contarino, A., Dellu, F., Koob, G.F., Smith, G.W., Lee, K.F., Vale, W., Gold, L.H., 1999. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1. Brain Res. 835, 1-9
41. Craft, R.M., 2008. Sex differences in analgesic, reinforcing, discriminative, and motoric effects of opioids. Exp. Clin. Psychopharmacol. 16, 376-385
42. Crowe, M.S., Nass, S.R., Gabella, K.M., Kinsey, S.G., 2014. The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behav. Immunity
43. Curtis, A.L., Grigoradis, D., Page, M.E., Rivier, J., Valentino, R.J., 1994. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies. J. Pharmacol. Exp. Ther. 268, 359-365
44. Curtis, A.L., Florin-Lechner, S.M., Pavcovich, L.A., Valentino, R.J., 1997. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmacol. Exp. Ther. 281, 163-172
45. Curtis, A.L., Bello, N.T., Valentino, R.J., 2001. Endogenous opioids in the locus coeruleus function to limit the noradrenergic response to stress. J. Neurosci. 21, RC152
46. Curtis, A.L., Bello, N.T., Connally, K.R., Valentino, R.J., 2002. Corticotropin-releasing factor neurons of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress. J. Neuroendocrinol. 14, 667-682
47. Curtis, A.L., Leiser, S.C., Snyder, K., Valentino, R.J., 2012. Predator stress engages corticotropin-releasing factor and opioid systems to alter the operating mode of locus coeruleus norepinephrine neurons. Neuropharmacology 62, 1737-1745
48. Dallman, M.F., Jones, M.T., Vernikos-Danellis, J., Ganong, W.F., 1972. Corticosteroid feedback control of ACTH secretion: rapid effects of bilateral adrenalectomy on plasma ACTH in the rat. Endocrinology 91, 961-968
49. Dautzenberg, F.M., Hauger, R.L., 2002. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23, 71-77
50. de Kloet, E.R., Joels, M., Holsboer, F., 2005. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463-475
51. Detke, M.J., Rickels, M., Lucki, I., 1995. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121, 66-72
52. Drolet, G., Van Bockstaele, E.B., Akaoka, H., et al., 1992. Robust enkephalin innervation of the locus coeruleus from the rostral medulla. J. Neurosci. 12, 3162-3174
53. Drolet, G., Dumont, E.C., Gosselin, I., Kinkead, R., Laforest, S., Trottier, J.F., 2001. Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol. Biol. Psychiatry 25, 729-741
54. Dumont, E.C., Kinkead, R., Trottier, J.F., Gosselin, I., Drolet, G., 2000. Effect of chronic psychogenic stress exposure on enkephalin neuronal activity and expression in the rat hypothalamic paraventricular nucleus. J. Neurochem. 75, 2200-2211
55. Dun, N.J., Dun, S.L., Shen, E., Tang, H., Huang, R., Chiu, T.H., 1995. c-fos expression as a marker of central cardiovascular neurons. Biol. Signals 4, 117-123
56. Duncan, G.E., Johnson, K.B., Breese, G.R., 1993. Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of fos-like immunoreactivity. J. Neurosci. 13, 3932-3943
57. Fareed, A., Eilender, P., Haber, M., Bremner, J., Whitfield, N., Drexler, K., 2013. Comorbid posttraumatic stress disorder and opiate addiction: a literature review. J. Addict. Dis. 32, 168-179
58. Foote, S.L., Aston-Jones, G., Bloom, F.E., 1980. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl. Acad. Sci. U. S. A. 77, 3033-3037
59. Foote, S.L., Bloom, F.E., Aston-Jones, G., 1983. Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63, 844-914
60. Funk, D., Amir, S., 2000. Circadian modulation of fos resonses to odor of the red fox, a rodent predator, in the rat olfactory system. Brain Res. 866, 262-267
61. George, S.A., Knox, D., Curtis, A.L., Aldridge, J.W., Valentino, R.J., Liberzon, I., 2013. Altered locus coeruleus-norepinephrine function following single prolonged stress. Eur. J. Neurosci. 37, 901-909
62. Girardot, M.N., Holloway, F.A., 1984. Intermittent cold water stress-analgesia in rats: cross-tolerance to morphine. Pharmacol. Biochem. Behav. 20, 631-633
63. Goeders, N.E., 2003. The impact of stress on addiction. Eur. Neuropsychopharmacol. 13, 435-441
64. Gold, P.W., Chrousos, G.P., 2002. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psych. 7, 254-275
65. Goldstein, A., Tachibana, S., Lowney, L.I., Hunkapiller, M., Hood, L., 1979. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U. S. A. 76, 6666-6670
66. Graham, J.C., Hoffman, G.E., Sved, A.F., 1995. c-fos expression in brain in response to hypotension and hypertension in conscious rats. J. Auton. Nerv. Sys. 55, 92-104
67. Grzanna, R., Molliver, M.E., 1980. The locus coeruleus in the rat: an immunohistochemical delineation. Neuroscience 5, 21-40
68. Gunduz-Cinar, O., Hill, M.N., McEwen, B.S., Holmes, A., 2013. Amygdala FAAH and anandamide: mediating protection and recovery from stress. Trends Pharmacol Sci. 34, 637-644
69. Gutman, D.A., Owens, M.J., Skelton, K.H., Thrivikraman, K.V., Nemeroff, C.B., 2003. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J. Pharmacol. Exp. Ther. 304, 874-880
70. Hauger, R.L., Risbrough, V., Oakley, R.H., Olivares-Reyes, J.A., Dautzenberg, F.M., 2009. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. N. Y. Acad. Sci. 1179, 120-143
71. Heilig, M., Thorsell, A., 2002. Brain neuropeptide Y (NPY) in stress and alcohol dependence. Rev. Neurosci. 13, 85-94
72. Heinrichs, S.C., Pich, E.M., Miczek, K.A., Britton, K.T., Koob, G.F., 1992. Corticotropinreleasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res. 581, 190-197
73. Heinrichs, S.C., Menzaghi, F., Merlo Pich, E., Britton, K.T., Koob, G.F., 1995. The role of CRF in behavioral aspects of stress. Ann. N. Y. Acad. Sci. 771, 92-104
74. Hillard, C.J., 2014. Stress regulates endocannabinoid-CB1 receptor signaling. Semin. Immunol.
75. Holbrook, T.L., Galarneau, M.R., Dye, J.L., Quinn, K., Dougherty, A.L., 2010. Morphine use after combat injury in Iraq and post-traumatic stress disorder. N. Engl. J Med. 362, 110-117
76. Hughes, J., Smith, T.W., Kosterlitz, H.W., Fothergill, L.A., Morgan, B.A., Morris, H.R., 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258, 577-580
77. Ishida, Y., Hashiguchi, H., Takeda, R., Ishizuka, Y., Mitsuyama, Y., Kannan, H., Nishimori, T., Nakahara, D., 2002. Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei. Synapse 45, 46-51
78. Ishimatsu, M., Williams, J.T., 1996. Synchronous activity in locus coeruleus results from dendritic interactions in pericoerulear regions. J. Neurosci. 16, 5196-5204
79. Jacobsen, L.K., Southwick, S.M., Kosten, T.R., 2001. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am. J Psychiatry 158, 1184-1190
80. Jedema, H.P., Grace, A.A., 2004. Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J. Neurosci. 24, 9703-9713
81. Ji, Y., Murphy, A.Z., Traub, R.J., 2006. Sex differences in morphine-induced analgesia of visceral pain are supraspinally and peripherally mediated. Am. J. Physiol Regul. Integr. Comp. Physiol. 291, R307-314
82. Jolas, T., Aghajanian, G.K., 1997. Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro Brain Res. 755, 229-245
83. Kakidani, H., Furutani, Y., Takahashi, H., Noda, M., Morimoto, Y., Hirose, T., Asai, M., Inayama, S., Nakanishi, S., Numa, S., 1982. Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature 298, 245-249
84. Kawahara, H., Kawahara, Y., Westerink, B.H., 2000. The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of norepinephrine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain. Eur. J. Pharmacol. 387, 279-286
85. Keck, M.E., Holsboer, F., Muller, M.B., 2004. Mouse mutants for the study of corticotropin-releasing hormone receptor function: development of novel treatment strategies for mood disorders. Ann. N. Y. Acad. Sci. 1018, 445-457
86. Kepler, K.L., Standifer, K.M., Paul, D., Kest, B., Pasternak, G.W., Bodnar, R.J., 1991. Gender effects and central opioid analgesia. Pain 45, 87-94
87. Kessler, R.C., McGonagle, K.A., Nelson, C.B., Hughes, M., Swartz, M., Blazer, D.G., 1994. Sex and depression in the National Comorbidity Survey. II: Cohort effects. J. Affect. Disord. 30, 15-26
88. Kessler, R.C., Chiu, W.T., Demler, O., Walters, E.E., 2005. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch. Gen. Psychiatry 62, 617-627
89. Kirby, L.G., Rice, K., Valentino, R.J., 2000. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 22, 148-162
90. Kirby, L.G., Freeman-Daniels, E., Lemos, J.C., Nunan, J.D., Lamy, C., Akanwa, A., Beck, S.G., 2008. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J. Neurosci. 28, 12927-12937
91. Kollack-Walker, S., Watson, S.J., Akil, H., 1997. Social stress in hamsters: defeat activates specific neurocircuits within the brain. J. Neurosci. 17, 8842-8865
92. Koob, G.F., Heinrichs, S.C., 1999. A role for corticotropin-releasing factor and urocortin in behavioral responses to stressors. Brain Res. 848, 141-152
93. Korf, J., Aghajanian, G.K., Roth, R.H., 1973. Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology 12, 933-938
94. Korte, S.M., Korte-Bouws, G.A., Bohus, B., Koob, G.F., 1994. Effect of corticotropinreleasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats. Physiol. Behav. 56, 115-120
95. Kozicz, T., 2007. On the role of Urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. General Comp. Endocrinol. 153, 235-240
96. Kreibich, A., Reyes, B.A., Curtis, A.L., Ecke, L., Chavkin, C., Van Bockstaele, E.J., Valentino, R.J., 2008. Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system. J. Neurosci. 28, 6516-6525
97. Kwok, C.H., Devonshire, I.M., Bennett, A.J., Hathway, G.J., 2014. Postnatal maturation of endogenous opioid systems within the periaqueductal grey and spinal dorsal horn of the rat. Pain 155, 168-178
98. Lacosta, S., Merali, Z., Anisman, H., 2000. Central monoamine activity following acute and repeated systemic interleukin-2 administration. Neuroimmunomodulation 8, 83-90
99. Larauche, M., Mulak, A., Tache, Y., 2012. Stress and visceral pain: from animal models to clinical therapies. Exp. Neurol. 233, 49-67
100. Lechner, S., Curtis, A., Brons, R., Valentino, R., 1997. Locus coeruleus activation by colon distention: role of corticotropin-releasing factor and excitatory amino acids. Brain Res. 756, 114-124
101. Lenz, H.J., Raedler, A., Geten, H., Vale, W.W., Rivier, J.E., 1988. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology 95, 1510-1517
102. Lewis, J.W., Cannon, J.T., Liebeskind, J.C., 1980. Opioid and nonopioid mechanisms of stress analgesia. Science 208, 623-625
103. Lightman, S.L., Young III, W.S., 1987. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal. Nature 328, 643-645
104. Ling, N., Burgus, R., Guillemin, R., 1976. Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamichypophysial origin with morphinomimetic activity. Proc. Natl. Acad. Sci. U. S A. 73, 3942-3946
105. Mague, S.D., Blendy, J.A., 2010. OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend,. 108, 172-182
106. Mague, S.D., Isiegas, C., Huang, P., Liu-Chen, L.Y., Lerman, C., Blendy, J.A., 2009. Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior. Proc. Natl. Acad. Sci. U. S. A. 106, 10847-10852
107. Maier, S.F., Watkins, L.R., 2005. Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci. Biobehav. Rev. 29, 829-841
108. Makino, S., Gold, P.W., Schulkin, J., 1994. Corticosterone effects on corticotropinreleasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular neucleus of the hypothalamus. Brain Res. 640, 105-112
109. Makino, S., Gold, P.W., Schulkin, J., 1994. Effects of corticosterone on CRH mRNA and content in the bed nuceus of the stria terminalis; comparison with the effects in he central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res. 657, 141-149
110. Makino, S., Smith, M.A., Gold, P.W., 2002. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress. Brain Res. 943, 216-223
111. Mansi, J.A., Laforest, S., Drolet, G., 2000. Effect of stress exposure on the activation pattern of enkephalin-containing perikarya in the rat ventral medulla. J. Neurochem. 74, 2568-2575
112. Martinez, V., Rivier, J., Wang, L., Tache, Y., 1997. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J. Pharmacol Exp. Ther. 280, 754-760
113. McEwen, B.S., 1998. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N. Y. Acad. Sci. 840, 33-44
114. McEwen, B.S., Stellar, E., 1993. Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med. 153, 2093-2101
115. Meunier, J.C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., Butour, J.L., Guillemot, J.C., Ferrara, P., Monsarrat, B., et al., 1995. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535
116. Miczek, K.A., 1991. Tolerance to the analgesic, but not discriminative stimulus effects of morphine after brief social defeat in rats. Psychopharmacology 104, 181-186
117. Miczek, K.A., Thompson, M.L., Shuster, L., 1982. Opioid-like analgesia in defeated mice. Science 215, 1520-1522
118. Miczek, K.A., Thompson, M.L., Shuster, L., 1986. Analgesia following defeat in an aggressive encounter: development of tolerance and changes in opioid receptors. Ann. N. Y. Acad. Sci. 467, 14-29
119. Mills, K.L., Teesson, M., Ross, J., Darke, S., 2007. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence. Addiction 102, 447-454
120. Milner, T.A., Burstein, S.R., Marrone, G.F., Khalid, S., Gonzalez, A.D., Williams, T.J., Schierberl, K.C., Torres-Reveron, A., Gonzales, K.L., McEwen, B.S., Waters, E.M., 2013. Stress differentially alters mu opioid receptor density and trafficking in parvalbumin-containing interneurons in the female and male rat hippocampus. Synapse 67, 757-772
121. Mogil, J.S., Pasternak, G.W., 2001. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53, 381-415
122. Muller, M.B., Uhr, M., Holsboer, F., Keck, M.E., 2004. Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice. Neuroendocrinology 79, 1-12
123. Nakanishi, S., Inoue, A., Kita, T., Nakamura, M., Chang, A.C., Cohen, S.N., Numa, S., 1979. Nucleotide sequence of cloned cDNA for bovine corticotropin-betalipotropin precursor. Nature 278, 423-427
124. Noda, M., Furutani, Y., Takahashi, H., Toyosato, M., Hirose, T., Inayama, S., Nakanishi, S., Numa, S., 1982. Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin. Nature 295, 202-206
125. Nothacker, H.P., Reinscheid, R.K., Mansour, A., Henningsen, R.A., Ardati, A., Monsma Jr., F.J., Watson, S.J., Civelli, O., 1996. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. U. S. A. 93, 8677-8682
126. Owens, M.J., Nemeroff, C.B., 1991. Physiology and pharmacology of corticotropinreleasing factor. Pharmacol. Revs. 43, 425-474
127. Page, M.E., Abercrombie, E.D., 1999. Discrete local application of corticotropinreleasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus. Synapse 33, 304-313
128. Page, M.E., Akaoka, H., Aston-Jones, G., Valentino, R.J., 1992. Bladder distention activates locus coeruleus neurons by an excitatory amino acid mechanism. Neuroscience 51, 555-563
129. Page, M.E., Berridge, C.W., Foote, S.L., Valentino, R.J., 1993. Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci. Lett. 164, 81-84
130. Pan, Y.X., Xu, J., Pasternak, G.W., 1996. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. Biochem. J. 315 (Pt 1), 11-13
131. Pasternak, G.W., 2004. Multiple opiate receptors: deja vu all over again. Neuropharmacology 47 (Suppl. 1), 312-323
132. Pert, C.B., Snyder, S.H., 1973. Opiate receptor: demonstration in nervous tissue. Science 179, 1011-1014
133. Pitman, R.K., van der Kolk, B.A., Orr, S.P., Greenberg, M.S., 1990. Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study. Arch. Gen. Psychiatry 47, 541-544
134. Rajkowski, J., Kubiak, P., Aston-Jones, G., 1994. Activity of locus coeruleus neurons in monkey: phasic and tonic changes correspond to altered vigilance. Brain Res Bull. 35, 607-616
135. Reul, J.M., Holsboer, F., 2002. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2, 23-33
136. Reyes, B.A., Valentino, R.J., Xu, G., Van Bockstaele, E.J., 2005. Hypothalamic projections to locus coeruleus neurons in rat brain. Eur. J. Neurosci. 22, 93-106
137. Ribeiro, S.C., Kennedy, S.E., Smith, Y.R., Stohler, C.S., Zubieta, J.K., 2005. Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1264-1280
138. Risbrough, V.B., Hauger, R.L., Roberts, A.L., Vale, W.W., Geyer, M.A., 2004. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J. Neurosci. 24, 6545-6552
139. Risbrough, V.B., Geyer, M.A., Hauger, R.L., Coste, S., Stenzel-Poore, M., Wurst, W., Holsboer, F., 2009. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology 34, 1494-1503
140. Rodgers, R.J., Randall, J.I., 1985. Social conflict analgesia: studies on naloxone antagonism and morphine cross-tolerance in male DBA/2 mice. Pharmacol. Biochem. Behav. 23, 883-887
141. Rossier, J., French, E.D., Rivier, C., Ling, N., Guillemin, R., Bloom, F.E., 1977. Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature 270, 618-620
142. Rouzade-Dominguez, M.-L., Curtis, A.L., Valentino, R.J., 2001. Role of Barrington's nucleus in the activation of rat locus coeruleus neurons by colonic distension. Brain Res. 917, 206-218
143. Rusnak, M., Kvetnansky, R., Jelokova, J., Palkovits, M., 2001. Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats. Brain Res. 899, 20-35
144. Sabban, E.L., Kvetnansky, R., 2001. Stress-triggered activation of gene expression in catecholaminergic systems: dynamics of transcriptional events. Trends Neurosci. 24, 91-98
145. Sakanaka, M., Shibasaki, T., Lederes, K., 1987. Corticotropin-releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxide-diaminobenzidene method. J. Comp. Neurol. 260, 256-298
146. Sakanaka, M., Magari, S., Shibasaki, T., Inoue, N., 1989. Co-localization of corticotropin-releasing factor- and enkephalin-like immunoreactivities in nerve cells of the rat hypothalamus and adjacent areas. Brain Res. 487, 357-362
147. Schulz, D.W., Mansbach, R.S., Sprouse, J., Braselton, J.P., Collins, J., Corman, M., Dunaiskis, A., Faraci, S., Schmidt, A.W., Seeger, T., Seymour, P., Tingley, F.D.I., Winston, E.N., Chen, Y.L., Heym, J., 1996. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc. Natl Acad. Sci. U. S. A. 93, 10477-10482
148. Schwartz, A.C., Bradley, R., Penza, K.M., Sexton, M., Jay, D., Haggard, P.J., Garlow, S.J., Ressler, K.J., 2006. Pain medication use among patients with posttraumatic stress disorder. Psychosomatics 47, 136-142
149. Smagin, G.N., Swiergiel, A.H., Dunn, A.J., 1994. Sodium nitroprusside infusions activate cortical and hypothalamic noradrenergic systems in rats. Neurosci. Res Comm. 14, 85-91
150. Smagin, G.N., Harris, R.B., Ryan, D.H., 1996. Corticotropin-releasing factor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci. Lett. 220, 167-170
151. Smith, M.A., Brady, L.S., Glowa, J., Gold, P.W., Herkenham, M., 1991. Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization. Brain Res. 544, 26-32
152. Smith, M.A., Banerjee, S., Gold, P.W., Glowa, J., 1992. Induction of c-fos mRNA in rat brain by conditioned and unconditioned stressors. Brain Res. 578, 135-141
153. Snyder, K., Wang, W.W., Han, R., McFadden, K., Valentino, R.J., 2012. Corticotropinreleasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility. Neuropsychopharmacology 37, 520-530
154. Sora, I., Takahashi, N., Funada, M., Ujike, H., Revay, R.S., Donovan, D.M., Miner, L.L., Uhl, G.R., 1997. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Nat Acad. Sci. U. S. A. 94, 1544-1549
155. Southwick, S.M., Bremner, J.D., Rasmusson, A., Morgan 3rd, C.A., Arnsten, A., Charney, D.S., 1999. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol. Psychiatry 46, 1192-1204
156. Staub, D.R., Lunden, J.W., Cathel, A.M., Dolben, E.L., Kirby, L.G., 2012. Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats. Psychoneuroendocrinology 37, 859-870
157. Sutton, R.E., Koob, G.F., LeMoal, M., Rivier, J., Vale, W., 1982. Corticotropin-releasing factor produces behavioral activation in rats. Nature 297, 331-333
158. Swanson, L.W., Hartman, B.K., 1976. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat using dopamine-B-hydroxylase as a marker. J. Comp. Neurol. 163, 467-506
159. Swanson, L.W., Sawchenko, P.E., Rivier, J., Vale, W., 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in rat brain: an immunohistochemical study. Neuroendocrinology 36, 165-186
160. Swerdlow, N.R., Geyer, M.A., Vale, W.W., Koob, G.F., 1986. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology
161. Tache, Y., Gunion, M., 1985. Corticotropin-releasing factor: central action to influence gastric secretion. Fed. Proc. 44, 255-258
162. Tache, Y., Goto, Y., Gunion, M., Vale, W., Rivier, J., Brown, M., 1983. Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor(CRF). Science 222, 935
163. Tache, Y., Monnikes, H., Bonaz, B., Rivier, J., 1993. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann. N. Y. Acad. Sci. 697, 233-243
164. Tazi, A., Dantzer, R., LeMoal, M., et al., 1987. Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats. Reg. Pept. 18, 37-42
165. Thierry, A.M., Javoy, F., Glowinski, J., Kety, S.S., 1968. Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat: modification of norpinephrine turnover. J. Pharmacol. Exp Ther. 163, 163-171
166. Tjoumakaris, S.I., Rudoy, C., Peoples, J., Valentino, R.J., Van Bockstaele, E.J., 2003. Cellular interactions between axon terminals containing endogenous opioid peptides or corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal pontine tegmentum. J. Comp. Neurol. 466, 445-456
167. Torres-Reveron, A., Khalid, S., Williams, T.J., Waters, E.M., Drake, C.T., McEwen, B.S., Milner, T.A., 2008. Ovarian steroids modulate leu-enkephalin levels and target leu-enkephalinergic profiles in the female hippocampal mossy fiber pathway. Brain Res. 1232, 70-84
168. Torres-Reveron, A., Williams, T.J., Chapleau, J.D., Waters, E.M., McEwen, B.S., Drake, C.T., Milner, T.A., 2009. Ovarian steroids alter mu opioid receptor trafficking in hippocampal parvalbumin GABAergic interneurons. Exp. Neurol. 219, 319-327
169. Usher, M., Cohen, J.D., Servan-Schreiber, D., Rajkowski, J., Aston-Jones, G., 1999. The role of locus coeruleus in the regulation of cognitive performance. Science 283, 549-554
170. Vale, W., Spiess, J., Rivier, C., Rivier, J., 1981. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and betaendorphin. Science 213, 1394-1397
171. Valentino, R.J., Aulisi, E., 1987. Carbachol-induced increases in locus coeruleus spontaneous activity are associated with disruption of sensory responses. Neurosci. Lett. 74, 297-303
172. Valentino, R.J., Foote, S.L., 1987. Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons. Neuroendocrinology 45, 28-36
173. Valentino, R.J., Van Bockstaele, E.J., 2001. Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids: potential for reciprocal interactions between stress and opioid sensitivity. Psychopharmacology 158, 331-342
174. Valentino, R.J., Van Bockstaele, E., 2008. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur. J. Pharmacol. 583, 194-203
175. Valentino, R.J., Wehby, R.G., 1988. Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress. Neuroendocrinology 48, 674-677
176. Valentino, R.J., Wehby, R.G., 1988. Morphine effects on locus coeruleus neurons are dependent on the state of arousal and availability of external stimuli: studies in anesthetized and unanesthetized rats. J. Pharmacol. Exp. Ther. 244, 1178-1186
177. Valentino, R.J., Wehby, R.G., 1989. Locus coeruleus discharge characteristics of morphine-dependent rats: effects of naltrexone. Brain Res. 488, 126-134
178. Valentino, R.J., Foote, S.L., Aston-Jones, G., 1983. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res. 270, 363-367
179. Valentino, R.J., Page, M.E., Curtis, A.L., 1991. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res. 555, 25-34
180. Valentino, R.J., Page, M., Van Bockstaele, E., Aston-Jones, G., 1992. Corticotropinreleasing factor innervation of the locus coeruleus region: distribution of fibers and sources of input. Neuroscience 48, 689-705
181. Valentino, R.J., Chen, S., Zhu, Y., Aston-Jones, G., 1996. Evidence for divergent projections of corticotropin-releasing hormone neurons of Barrington's nucleus to the locus coeruleus and spinal cord. Brain Res. 732, 1-15
182. Valentino, R.J., Rudoy, C., Saunders, A., Liu, X.B., Van Bockstaele, E.J., 2001. Corticotropin-releasing factor is preferentially colocalized with excitatory rather than inhibitory amino acids in axon terminals in the peri-locus coeruleus region. Neuroscience 106, 375-384
183. Van Bockstaele, E.J., Colago, E.E., Valentino, R.J., 1996. Corticotropin-releasing factorcontaining axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J. Comp. Neurol. 364, 523-534
184. Van Bockstaele, E.J., Colago, E.E.O., Valentino, R.J., 1998. Amygdaloid corticotropinreleasing factor targets locus coeruleus dendrites: substrate for the coordination of emotional and cognitive limbs of the stress response. J. Neuroendocrinol. 10, 743-757
185. Van Bockstaele, E.J., Peoples, J., Valentino, R.J., 1999. A.E. Bennett Research Award Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents. Biol. Psychiatry 46, 1352-1363
186. van der Kolk, B.A., Greenberg, M.S., Orr, S.P., Pitman, R.K., 1989. Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder. Psychopharmacol Bull. 25, 417-421
187. Van Kempen, T.A., Kahlid, S., Gonzalez, A.D., Spencer-Segal, J.L., Tsuda, M.C., Ogawa, S., McEwen, B.S., Waters, E.M., Milner, T.A., 2013. Sex and estrogen receptor expression influence opioid peptide levels in the mouse hippocampal mossy fiber pathway. Neurosci. Lett. 552, 66-70
188. Wang, X., Traub, R.J., Murphy, A.Z., 2006. Persistent pain model reveals sex difference in morphine potency. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291, R300-306
189. Weaver, I.C., Diorio, J., Seckl, J.R., Szyf, M., Meaney, M.J., 2004. Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Ann. N Y. Acad. Sci. 1024, 182-212
190. Williams, J.T., Marshall, K.C., 1987. Membrane properties and adrenergic responses in locus coeruleus neurons of young rats. J. Neurosci. 7, 3687-3694
191. Williams, J.T., North, R.A., 1984. Opiate receptor interactions on single locus coeruleus neurons. Mol. Pharm. 26, 489-497
192. Wong, M.L., Kling, M.A., Munson, P.J., Listwak, S., Licinio, J., Prolo, P., Karp, B., McCutcheon, I.E., Geracioti Jr., T.D., DeBellis, M.D., Rice, K.C., Goldstein, D.S., Veldhuis, J.D., Chrousos, G.P., Oldfield, E.H., McCann, S.M., Gold, P.W., 2000. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc. Natl. Acad. Sci. U. S. A. 97, 325-330
193. Xu, G.P., Van Bockstaele, E., Reyes, B., Bethea, T., Valentino, R.J., 2004. Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress. J. Neurosci. 24, 8193-8197
194. Zhu, H., Zhou, W., 2001. Morphine induces synchronous oscillatory discharges in the rat locus coeruleus. J. Neurosci. 21, RC179
195. Zubieta, J.K., Smith, Y.R., Bueller, J.A., Xu, Y., Kilbourn, M.R., Jewett, D.M., Meyer, C.R., Koeppe, R.A., Stohler, C.S., 2001. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293, 311-315